Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding

The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>

Fast Funding for COVID-19 Science

If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant.

Deadline: Fast Grant decisions are made in under 48 hours. Apply Now!

Apply for a Fast Funding grant now>>


Department of Defense Lung Cancer Research Program

The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about the DoD Lung Award>>



NIH/NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award

The purpose of this NCI award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. Yale may nominate one candidate to apply for this award.

Internal Application Deadline: October 16, 2020


Fertility Status as a Marker for Overall Health (R01 and R21)

The purpose of this FOA is to support research that explores the premise that fertility status can be a marker for overall health.

Application Deadline: October 19, 2020

Learn more about the fertility R01 and R21>>


NCI Clinical and Translational Exploratory/Developmental Studies (R21)

This FOA supports preclinical and early phase clinical research, as well as correlative studies, directly related to advancements in cancer treatment, diagnosis, prevention, symptom management, or reduction of cancer health disparities.

Application Deadline: October 20, 2020


Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)

The purpose of this FOA is to stimulate the development of new cancer data visualization methods and tools that have the potential to make data aligned with the Cancer Moonshot more explorable and interpretable by the broader cancer research community.

Applicaiton Deadline: October 30, 2020


Cancer Research Institute Cancer Immunotherapy Translational Research Grant

This grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Letter of Intent Due: November 1, 2020


NCI Outstanding Investigator Award (R35)

The objective of the NCI OIA is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research.

Application Deadline: November 6, 2020


3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2)

Through this FOA, the NCI, as a part of its Beau Biden Cancer Moonshot Initiative, invites submission of applications requesting support for projects that will accelerate cancer research.

Application Deadline: November 9, 2020

Learn more about the NCI UH2>>

NCI Pediatric In Vivo Testing Program (U01)

This FOA is for Research Teams to form the NCI Pediatric in Vivo Testing Program
.
Application Deadline: November 9, 2020


DoD Rare Cancers Research Program

These FOAs aim to greatly improve outcomes for people with rare cancer through discovery and community building, and expansion of knowledge across the cancer landscape.
  • Concept Award – Letter of Intent Due: November 12, 2020
  • Idea Development Award – Letter of Intent Due: November 12, 2020
  • Resource and Community Development Award – Letter of Intent Due: November 12, 2020

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Application Deadline: November 18, 2020



Glioblastoma Therapeutics Network (U19)

The overall goal of this FOA is to improve the treatment of adult glioblastoma (GBM) by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them in the clinic.

Application Deadline: November 19, 2020



Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01)

Through this FOA, the NCI intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection.

Application Deadline: December 15, 2020

Alex's Lemonade Stand RUNX1 Early Career Investigator Grant

This grant is a 3-year award designed to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FDP.

Application Deadline: December 16, 2020

Learn more about the RUNX1 Grant>>


NCI Research Specialist Awards

Core-Based Award: Application Deadline - January 4, 2021
This FOA invites grant applications in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists.
Laboratory-Based Award: Application Deadline - January 4, 2021
This FOA invites grant applications in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.


Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01)

The purpose of this FOA is to bring a highly sensitive imaging technology capable of detecting very small (1-3 mm3) tumors in vivo to clinical utility.

Application Deadline: February 10, 2021


Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01)

The overarching goal of this FOA is to expand comparative simulation modeling approaches developed by CISNET to new cancer organ sites beyond the sites which have been previously funded (breast, colorectal, prostate, lung, esophageal, and cervical) under CISNET.

Application Deadline: January 20, 2021



Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01)

The purpose of this FOA is to solicit applications to develop, adapt, and test individual-, community- or multilevel interventions to address modifiable risk factors for cancer in rural populations.

Application Deadline: March 15, 2021

Learn more about the rural population award>>

Cancer Grand Challenges Program

The NCI and Cancer Research UK (CRUK) are partnering to fund the Cancer Grand Challenges program. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer. These nine challenges are aimed at solving complex problems in cancer research, which, if solved, could have a transformative impact towards progress.

Application Deadline: April 22, 2021